Cerebral blood flow in obsessive–compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders

[1]  S. Houle,et al.  Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. , 2001, The American journal of psychiatry.

[2]  W. E. Barnes,et al.  Changes in Regional Cerebral Blood Flow After Electroconvulsive Therapy for Depression , 2001, The journal of ECT.

[3]  R. Davidson,et al.  Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. , 2001, The American journal of psychiatry.

[4]  P. Jerabek,et al.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response , 2000, Biological Psychiatry.

[5]  W. Drevets Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[6]  S. Rauch,et al.  Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. , 2000, The Psychiatric clinics of North America.

[7]  J. Piacentini,et al.  Obsessive-compulsive disorder in children. , 2000, The Psychiatric clinics of North America.

[8]  S. Stahl,et al.  Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. , 2000, Archives of general psychiatry.

[9]  S. Alborzian,et al.  Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder , 1999, Neuropsychopharmacology.

[10]  S. Alborzian,et al.  Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine , 1999, Psychiatry Research: Neuroimaging.

[11]  P. Liddle,et al.  Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. , 1999, Archives of general psychiatry.

[12]  M S Buchsbaum,et al.  Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. , 1999, The American journal of psychiatry.

[13]  Michael E Phelps,et al.  FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder , 1998, Psychiatry Research: Neuroimaging.

[14]  M. Kocmur,et al.  Evaluation of brain perfusion with technetium-99m bicisate single-photon emission tomography in patients with depressive disorder before and after drug treatment , 1998, European Journal of Nuclear Medicine.

[15]  O. Speck,et al.  1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum , 1997, Psychiatry Research: Neuroimaging.

[16]  S. Kennedy,et al.  A Review of Functional Neuroimaging in Mood Disorders: Positron Emission Tomography and Depression , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[17]  D. Murphy,et al.  Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. , 1997, The American journal of psychiatry.

[18]  G. Pearlson,et al.  Neuroimaging in Affective Disorders: Accomplishments and Shortfalls , 1997 .

[19]  P. Fox,et al.  Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.

[20]  Monte S. Buchsbaum,et al.  Effect of sertraline on regional metabolic rate in patients with affective disorder , 1997, Biological Psychiatry.

[21]  B. Greenberg,et al.  Psychobiology of obsessive-compulsive disorder: Anatomical and physiological considerations , 1997 .

[22]  B. Lippitz,et al.  Obsessive compulsive disorder and the right hemisphere: topographic analysis of lesions after anterior capsulotomy performed with thermocoagulation. , 1997, Acta neurochirurgica. Supplement.

[23]  M E Phelps,et al.  Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[24]  R. Post,et al.  Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. , 1996, Psychopharmacology bulletin.

[25]  G. Pearlson,et al.  Pitfalls of SPECT studies of acute ethanol-induced changes in cerebral blood flow. , 1995, The American journal of psychiatry.

[26]  F. Rubia,et al.  Cerebral perfusion, electrical activity and effects of serotonergic treatment in obsessive-compulsive disorder. A preliminary study. , 1995, Neuropsychobiology.

[27]  M. Reith,et al.  Effects of Locally Applied Cocaine, Lidocaine, and Various Uptake Blockers on Monoamine Transmission in the Ventral Tegmental Area of Freely Moving Rats: A Microdialysis Study on Monoamine Interrelationships , 1994, Journal of neurochemistry.

[28]  C. McDougle,et al.  Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. , 1994, Archives of general psychiatry.

[29]  E. Hollander Current insights in obsessive compulsive disorder , 1994 .

[30]  G. Pearlson,et al.  Mapping of SPECT regional cerebral perfusion abnormalities in obsessive‐compulsive disorder , 1994, Human brain mapping.

[31]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[32]  Klaus P. Ebmeier,et al.  State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. , 1993, Journal of affective disorders.

[33]  Alan C. Evans,et al.  A Three-Dimensional Statistical Analysis for CBF Activation Studies in Human Brain , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  P Pietrini,et al.  Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. , 1992, Archives of general psychiatry.

[35]  T. Insel,et al.  Toward a neuroanatomy of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[36]  J. Mazziotta,et al.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[37]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[38]  Karl J. Friston,et al.  Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  G. Pearlson,et al.  Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. , 1991, The American journal of psychiatry.

[40]  B. Pate,et al.  Regional Cerebral Glucose Metabolism in Major Depressive Disorder * , 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[41]  S. Pappatà,et al.  Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.

[42]  D. Murphy,et al.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. , 1990, Archives of general psychiatry.

[43]  Karl J. Friston,et al.  The Relationship between Global and Local Changes in PET Scans , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  D. Jermain,et al.  Pharmacotherapy of Obsessive‐Compulsive Disorder , 1990, Pharmacotherapy.

[45]  M. Torrens Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[46]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[47]  Karl J. Friston,et al.  Localisation in PET Images: Direct Fitting of the Intercommissural (AC—PC) Line , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  J. Rapoport,et al.  Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. , 1989, Archives of general psychiatry.

[49]  J. Rapoport,et al.  Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. , 1989, Archives of general psychiatry.

[50]  Judith L. Rapoport,et al.  Obsessive-compulsive disorder in children and adolescents , 1989 .

[51]  T. Greitz,et al.  Regional cerebral glucose metabolism in anxiety disorders studied with positron emission tomography before and after psychosurgical intervention. A preliminary report. , 1986, Acta radiologica. Supplementum.

[52]  J C Mazziotta,et al.  Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. , 1985, Archives of general psychiatry.

[53]  M. Jenike Obsessive compulsive disorder. , 1983, Comprehensive psychiatry.

[54]  R. Adler,et al.  The Geometry of Random Fields , 1982 .

[55]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.